Cannabis-derived cannabinoids may reduce neuroinflammation and oxidative stress. By acting on the endocannabinoid system (ECS), they may preserve blood–brain barrier integrity and limit neural damage in Alzheimer’s, Parkinson’s, multiple sclerosis and Huntington’s disease according to a review.
Read Full Article
#Cannabinoids #Neuroinflammation #EndocannabinoidSystem #BloodBrainBarrier #NeurodegenerativeDiseases
Read Full Article
#Cannabinoids #Neuroinflammation #EndocannabinoidSystem #BloodBrainBarrier #NeurodegenerativeDiseases
MDPI
Cannabinoids, the Blood–Brain Barrier, and Neurodegeneration: Mechanisms, Dysregulation, and Therapeutic Perspectives
Neurodegenerative diseases are a large and complex group of neurological disorders, including Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, multiple sclerosis, and so on, which adversely affect the physical and mental health of millions…